Tvardi Therapeutics, Inc. (TVRD) 8-K Current Report — March 6, 2026
Filed: March 6, 2026
Health Care
Pharmaceutical PreparationsTvardi Therapeutics, Inc. (TVRD) 8-K current report filed with SEC EDGAR on March 6, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 8.01: Other Events
Tvardi Therapeutics, Inc. 8-K Mar 6, 2026 Event Analysis
Item 8.01 · Other Events
- • 2026 Annual Meeting set for June 9, 2026
- • Rule 14a-8 stockholder proposal deadline: March 16, 2026
Get deeper insights on Tvardi Therapeutics, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.